Kindly MD, Inc. Files Amendment to 8-K Report

Ticker: NAKAW · Form: 8-K/A · Filed: Aug 26, 2025 · CIK: 1946573

Kindly Md, Inc. 8-K/A Filing Summary
FieldDetail
CompanyKindly Md, Inc. (NAKAW)
Form Type8-K/A
Filed DateAug 26, 2025
Risk Levellow
Pages4
Reading Time5 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: amendment, sec-filing, corporate-disclosure

TL;DR

Kindly MD filed an amendment to its 8-K, check for updates.

AI Summary

Kindly MD, Inc. filed an amendment (8-K/A) on August 26, 2025, to a previous report dated August 11, 2025. This amendment pertains to "Other Events" and "Financial Statements and Exhibits" but does not provide specific details on the nature of these events or financial information within the provided text.

Why It Matters

This filing indicates a formal update or correction to a previous SEC filing by Kindly MD, Inc., suggesting ongoing corporate actions or disclosures that may be relevant to investors.

Risk Assessment

Risk Level: low — The filing is an amendment to a previous report and does not contain new material financial information or significant corporate events that would inherently increase risk.

Key Players & Entities

  • Kindly MD, Inc. (company) — Registrant
  • 001-42103 (company) — SEC File Number
  • 84-3829824 (company) — IRS Employer Identification Number
  • August 11, 2025 (date) — Earliest event reported date
  • August 26, 2025 (date) — Filing date

FAQ

What specific "Other Events" are being reported or amended by Kindly MD, Inc. in this 8-K/A filing?

The provided text for the 8-K/A filing indicates 'Other Events' as an item information, but does not specify the details of these events.

What "Financial Statements and Exhibits" are being amended or filed with this 8-K/A?

The filing lists 'Financial Statements and Exhibits' as an item information, but the specific contents of these are not detailed in the provided text.

What was the original filing date that this 8-K/A is amending?

This 8-K/A is an amendment to a report where the earliest event reported was August 11, 2025.

What is the principal executive office address for Kindly MD, Inc.?

The principal executive offices are located at 5097 South 900 East, Suite 100, Salt Lake City, UT 84117.

What is the telephone number for Kindly MD, Inc.?

The registrant's telephone number is (385) 388-8220.

Filing Stats: 1,249 words · 5 min read · ~4 pages · Grade level 11 · Accepted 2025-08-26 06:42:51

Key Financial Figures

  • $0.001 — ch Registered Common Stock, par value $0.001 NAKA The Nasdaq Stock Market LLC

Filing Documents

01 Other Events

Item 8.01 Other Events. The Company is filing this amendment to supplement its prior disclosures in connection with the Merger, the PIPE Financings, and related transactions described in the Initial Form 8-K. Specifically, the Company is providing additional risk factors addressing cybersecurity and data privacy matters and risks related to the bitcoin treasury strategy (the " Supplemental Risk Factors "), as well as updated Management's Discussion and Analysis and Information about Nakamoto disclosures relevant to its business. These updates are intended to supplement and update the disclosures previously included in the Company's public filings, including those under the headings "Risk Factors," "Management's Discussion and Analysis," and "Information About Nakamoto" in the Company's Definitive Information Statement (filed with the SEC on July 22, 2025), Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (filed with the SEC on August 5, 2025), and the Company's Annual Report on Form 10-K for the year ended December 31, 2024 (filed with the SEC on March 28, 2025, as amended). The supplemental risk factors related to the bitcoin treasury strategy, cybersecurity and data privacy are filed herewith as Exhibit 99.3 to this Form 8-K/A and are incorporated herein by reference. Management's Discussion and Analysis and Information About Nakamoto disclosures are filed herewith as Exhibits 99.5, 99.6 and 99.7 to this Form 8-K/A and are also incorporated herein by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (a) Financial Statements of Business Acquired. The audited financial statements (and notes thereto) of Nakamoto Holdings, Inc. as of April 30, 2025, and for the period from March 6, 2025 (inception) to April 30, 2025, are filed as Exhibit 99.1 to this Form 8-K/A. The unaudited financial statements (and notes thereto) of Nakamoto Holdings, Inc. as of June 30, 2025, and for the period from March 6, 2025 (inception) to June 30, 2025, are filed as Exhibit 99.2 to this Form 8-K/A. (b) Pro Forma Financial Information. The unaudited pro forma condensed combined financial information reflecting the acquisition of Nakamoto Holdings, Inc., including the unaudited pro forma condensed combined balance sheet as of June 30, 2025 and the unaudited pro forma condensed combined statement of operations for the sixth months ended June 30, 2025 and for the year ended December 31, 2024, are filed as Exhibit 99.3 to this Form 8-K/A. (d) Exhibits. Exhibit No. Description of Exhibit 23.1 Consent of Wolf & Company, P.C. 99.1 Audited Financial Statements of Nakamoto Holdings, Inc. as of April 30, 2025, and for the period from March 6, 2025 (inception) to April 30, 2025 (incorporated by reference to the definitive information statement filed by the Company on July 22, 2025). 99.2 Unaudited Financial Statements of Nakamoto Holdings, Inc. as of June 30, 2025, and for the period from March 6, 2025 (inception) to June 30, 2025. 99.3 Unaudited pro forma condensed combined financial statements of Kindly MD, Inc. giving effect to the acquisition of Nakamoto Holdings, Inc., including the unaudited pro forma condensed combined balanced sheet as of June 30, 2025, and the unaudited pro forma combined statement of operations for the three-months ended June 30, 2025, and the year ended December 31, 2024. 99.4 Supplemental Risk Factors 99.5 Management Discussion and Analysis for the period from March 6, 2025 (inception) to Ju

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunder duly authorized. KINDLY MD, INC. Dated: August 25, 2025 By : /s/ David Bailey David Bailey Chief Executive Officer 3

View Full Filing

View this 8-K/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.